We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current 0NLY market cap is 439.06M. The company's latest EPS is EUR 2.0786 and P/E is 10.84.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 791.87M | 884.89M | 1.04B | 1.82B | 1.99B |
| Operating Income | 73.21M | 91.72M | 138.97M | 448.16M | 205.45M |
| Net Income | 52.97M | 63.38M | 93.2M | 315.63M | 132.02M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 424.95M | 529.2M | 678.62M | 1.13B | 1.3B |
| Total Liabilities | 86.03M | 138.38M | 168.75M | 310.16M | 385.36M |
| Total Equity | 338.92M | 390.82M | 509.87M | 818.46M | 911.83M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 44.33M | 71.68M | 117.18M | 325.03M | 26.09M |
| Investing | -979k | -87.68M | -46.56M | -113.62M | -266.43M |
| Financing | -3.93M | 2.24M | -18.76M | -18.48M | 112.21M |
| Market Cap | 439.06M |
| Price to Earnings Ratio | 10.84 |
| Price to Sales Ratio | 0.72 |
| Price to Cash Ratio | 8.41 |
| Price to Book Ratio | 1.57 |
| Dividend Yield | - |
| Shares Outstanding | 63.52M |
| Average Volume (1 week) | 7.52k |
| Average Volume (1 Month) | 6.81k |
| 52 Week Change | 0.00% |
| 52 Week High | 6.9125 |
| 52 Week Low | 6.9125 |
| Spread (Intraday) | 0.35 (4.87%) |
| Company Name | Verbio Se |
| Address |
thura mark 18 zoerbig 06780 |
| Website | https://www.verbio.de |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
